← Back to headlines
Analysts Raise Amgen Price Targets Ahead of Q1 Earnings
Morgan Stanley has raised its price target for Amgen (AMGN) ahead of its Q1 earnings report, while Truist also lifted its outlook based on pipeline strength.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
